Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Clinical Pharmacology and Therapeutics
|
June 15, 2020
Accelerating the Development of Personalized Cancer Immunotherapy by Integrating Molecular Patients' Profiles with Dynamic Mathematical Models
Zvia Agur, Moran Elishmereni, Urszula Foryś, et al.
Alternatives to Laboratory Animals : ATLA
|
October 8, 2009
Use of virtual patient populations for rescuing discontinued drug candidates and for reducing the number of patients in clinical trials
Marina Kleiman, Yael Sagi, Naamah Bloch, et al.
Cancer Immunology, Immunotherapy : CII
|
September 8, 2007
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics
Natalie Kronik, Yuri Kogan, Vladimir Vainstein, et al.
Plos One
|
July 15, 2017
Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model
Gili Hochman, Karin Halevi-Tobias, Yuri Kogan, et al.
Journal of Theoretical Biology
|
January 3, 2012
Strategies for cancer stem cell elimination: insights from mathematical modeling
Vladimir Vainstein, Oleg U Kirnasovsky, Yuri Kogan, et al.
Expert Opinion on Biological Therapy
|
August 27, 2016
Employing dynamical computational models for personalizing cancer immunotherapy
Zvia Agur, Karin Halevi-Tobias, Yuri Kogan, et al.
American Journal of Hematology
|
June 8, 2012
Analyzing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient database
Ofir Shukron, Vladimir Vainstein, Andrea Kündgen, et al.
Frontiers in Medicine
|
March 30, 2026
Dysregulated metabolic homeostasis as a unifying death mechanism underlying the diverse clinical manifestations of COVID-19: insights from a retrospective analysis of sequential blood variables
Zvia Agur, Yuri Kogan, Anat Ben Yaacov, et al.
Plos Computational Biology
|
October 25, 2011
An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancers
Moran Elishmereni, Yuri Kheifetz, Henrik Søndergaard, et al.
Cancer Research
|
March 17, 2012
Reconsidering the paradigm of cancer immunotherapy by computationally aided real-time personalization
Yuri Kogan, Karin Halevi-Tobias, Moran Elishmereni, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Clinical Pharmacology and Therapeutics
|
June 15, 2020
Accelerating the Development of Personalized Cancer Immunotherapy by Integrating Molecular Patients' Profiles with Dynamic Mathematical Models
Zvia Agur, Moran Elishmereni, Urszula Foryś, et al.
Alternatives to Laboratory Animals : ATLA
|
October 8, 2009
Use of virtual patient populations for rescuing discontinued drug candidates and for reducing the number of patients in clinical trials
Marina Kleiman, Yael Sagi, Naamah Bloch, et al.
Cancer Immunology, Immunotherapy : CII
|
September 8, 2007
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics
Natalie Kronik, Yuri Kogan, Vladimir Vainstein, et al.
Plos One
|
July 15, 2017
Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model
Gili Hochman, Karin Halevi-Tobias, Yuri Kogan, et al.
Journal of Theoretical Biology
|
January 3, 2012
Strategies for cancer stem cell elimination: insights from mathematical modeling
Vladimir Vainstein, Oleg U Kirnasovsky, Yuri Kogan, et al.
Expert Opinion on Biological Therapy
|
August 27, 2016
Employing dynamical computational models for personalizing cancer immunotherapy
Zvia Agur, Karin Halevi-Tobias, Yuri Kogan, et al.
American Journal of Hematology
|
June 8, 2012
Analyzing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient database
Ofir Shukron, Vladimir Vainstein, Andrea Kündgen, et al.
Frontiers in Medicine
|
March 30, 2026
Dysregulated metabolic homeostasis as a unifying death mechanism underlying the diverse clinical manifestations of COVID-19: insights from a retrospective analysis of sequential blood variables
Zvia Agur, Yuri Kogan, Anat Ben Yaacov, et al.
Plos Computational Biology
|
October 25, 2011
An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancers
Moran Elishmereni, Yuri Kheifetz, Henrik Søndergaard, et al.
Cancer Research
|
March 17, 2012
Reconsidering the paradigm of cancer immunotherapy by computationally aided real-time personalization
Yuri Kogan, Karin Halevi-Tobias, Moran Elishmereni, et al.
Page
of 4